Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Pfizer claims new 5-HT2C receptor modulators and their use in sexual disorders

Feb. 6, 2003

Cialis now available for prescription in several markets

Feb. 5, 2003

GenoMed evaluates intravenous drug regimen for acute kidney failure

Feb. 3, 2003

Second filing announced for YM-905

Jan. 30, 2003

Kissei presents potent and selective beta3-adrenoceptor agonists for bladder dysfunction

Jan. 29, 2003

Nastech reacquires rights to intranasal product for sexual dysfunction

Jan. 28, 2003

Lilly Icos team discovers new tetracyclic PDE5 inhibitors

Jan. 27, 2003

PT-141 effective in ED patients who fail to respond to Viagra

Jan. 24, 2003

European launch of Cialis under way

Jan. 24, 2003

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Jan. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...